REFRACTORY ACUTE MYELOID LEUKEMIA
Clinical trials for REFRACTORY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take aim at stubborn leukemia
Disease control Not yet recruitingThis early-phase study tests a new treatment called BSB-2002 for adults with a specific type of acute myeloid leukemia (AML) that has returned or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and att…
Matched conditions: REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
New hope for older leukemia patients: targeted radiation before transplant may reduce side effects
Disease control Not yet recruitingThis study tests a new way to prepare older patients (50 and older) with leukemia or MDS that has not responded to treatment for a stem cell transplant. Instead of full-body radiation, they receive targeted radiation to the bone marrow and lymph nodes, plus two chemotherapy drugs…
Matched conditions: REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 18, 2026 12:13 UTC